Cardiovascular diseases (CVDs) are one of the leading causes of death worldwide. Recent times have witnessed an enormous increase in the rate of myocardial infarction owing to various factors. Cardiac biomarkers play a key role in the detection and prognosis of myocardial infarction.
With the aim of providing reliable and outstanding diagnostic and research services, Stellixir runs rapid and accurate cardiac biomarker detection services for myocardial infarction.
|B-type Natriuretic Peptide (BNP) assay|
|Creatine Kinase-MB (CK-MB) assay|
|Heart-type fatty acid-binding protein (H-FABP) assay|